AAAAAA

   
Results: 1-21 |
Results: 21
ULCER SURGERY IN ESTONIA, A CONSEQUENCE OF DRUG DELAY
Authors: KIIVET RA BERGMAN U SJOSTEDT S SJOQVIST F
Citation: Ra. Kiivet et al., ULCER SURGERY IN ESTONIA, A CONSEQUENCE OF DRUG DELAY, Lancet, 351(9096), 1998, pp. 146-146
DENGLER,HANS,J - IN-MEMORIAM
Authors: SJOQVIST F EICHELBAUM M DAHLQVIST R
Citation: F. Sjoqvist et al., DENGLER,HANS,J - IN-MEMORIAM, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 495-495
CYP2D6 AND CYP2C19 GENOTYPES IN AN ELDERLY SWEDISH POPULATION
Authors: YAMADA H DAHL ML LANNFELT L VIITANEN M WINBLAD B SJOQVIST F
Citation: H. Yamada et al., CYP2D6 AND CYP2C19 GENOTYPES IN AN ELDERLY SWEDISH POPULATION, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 479-481
DRUG UTILIZATION 90-PERCENT - A SIMPLE METHOD FOR ASSESSING THE QUALITY OF DRUG PRESCRIBING
Authors: BERGMAN U POPA C TOMSON Y WETTERMARK B EINARSON TR ABERG H SJOQVIST F
Citation: U. Bergman et al., DRUG UTILIZATION 90-PERCENT - A SIMPLE METHOD FOR ASSESSING THE QUALITY OF DRUG PRESCRIBING, European Journal of Clinical Pharmacology, 54(2), 1998, pp. 113-118
DRUG-USE IN ESTONIA IN 1994-1995 - A FOLLOW-UP FROM 1989 AND COMPARISON WITH 2 NORDIC COUNTRIES
Authors: KIIVET RA BERGMAN U ROOTSLANE L RAGO L SJOQVIST F
Citation: Ra. Kiivet et al., DRUG-USE IN ESTONIA IN 1994-1995 - A FOLLOW-UP FROM 1989 AND COMPARISON WITH 2 NORDIC COUNTRIES, European Journal of Clinical Pharmacology, 54(2), 1998, pp. 119-124
PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES
Authors: YUE QY ZHONG ZH TYBRING G DALEN P DAHL ML BERTILSSON L SJOQVIST F
Citation: Qy. Yue et al., PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 384-390
QUICK ONSET OF SEVERE ABDOMINAL-PAIN AFTER CODEINE IN AN ULTRARAPID METABOLIZER OF DEBRISOQUINE
Authors: DALEN P FRENGELL C DAHL ML SJOQVIST F
Citation: P. Dalen et al., QUICK ONSET OF SEVERE ABDOMINAL-PAIN AFTER CODEINE IN AN ULTRARAPID METABOLIZER OF DEBRISOQUINE, Therapeutic drug monitoring, 19(5), 1997, pp. 543-544
DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS IN A RUSSIAN POPULATION LIVING IN ESTONIA
Authors: MARANDI T DAHL ML RAGO L KIIVET R SJOQVIST F
Citation: T. Marandi et al., DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS IN A RUSSIAN POPULATION LIVING IN ESTONIA, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 257-260
DEBRISOQUIN AND S-MEPHENYTOIN HYDROXYLATION PHENOTYPES AND CYP2D6 GENOTYPES IN AN ESTONIAN POPULATION
Authors: MARANDI T DAHL ML KIIVET RA RAGO L SJOQVIST F
Citation: T. Marandi et al., DEBRISOQUIN AND S-MEPHENYTOIN HYDROXYLATION PHENOTYPES AND CYP2D6 GENOTYPES IN AN ESTONIAN POPULATION, Pharmacology & toxicology, 78(5), 1996, pp. 303-307
OPENING ADDRESS AT THE 1ST CONGRESS OF THE CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS
Authors: SJOQVIST F
Citation: F. Sjoqvist, OPENING ADDRESS AT THE 1ST CONGRESS OF THE CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS, Therapie, 51(4), 1996, pp. 337-340
THE CYP2D6 GENOTYPE PREDICTS THE ORAL CLEARANCE OF THE NEUROLEPTIC AGENTS PERPHENAZINE AND ZUCLOPENTHIXOL
Authors: JERLING M DAHL ML ABERGWISTEDT A LILJENBERG B LANDELL NE BERTILSSON L SJOQVIST F
Citation: M. Jerling et al., THE CYP2D6 GENOTYPE PREDICTS THE ORAL CLEARANCE OF THE NEUROLEPTIC AGENTS PERPHENAZINE AND ZUCLOPENTHIXOL, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 423-428
ANTIDEPRESSANTS AND DRUG-METABOLIZING-ENZYMES - EXPERT GROUP-REPORT
Authors: MEYER UA AMREIN R BALANT LP BERTILSSON L EICHELBAUM M GUENTERT TW HENAUER S JACKSON P LAUX G MIKKELSEN H PECK C POLLOCK BG PRIEST R SJOQVIST F DELINISTULA A
Citation: Ua. Meyer et al., ANTIDEPRESSANTS AND DRUG-METABOLIZING-ENZYMES - EXPERT GROUP-REPORT, Acta psychiatrica Scandinavica, 93(2), 1996, pp. 71-79
GENETIC-ANALYSIS OF THE CYP2D LOCUS IN RELATION TO DEBRISOQUINE HYDROXYLATION CAPACITY IN KOREAN, JAPANESE AND CHINESE SUBJECTS
Authors: DAHL ML YUE QY ROH HK JOHANSSON I SAWE J SJOQVIST F BERTILSSON L
Citation: Ml. Dahl et al., GENETIC-ANALYSIS OF THE CYP2D LOCUS IN RELATION TO DEBRISOQUINE HYDROXYLATION CAPACITY IN KOREAN, JAPANESE AND CHINESE SUBJECTS, Pharmacogenetics, 5(3), 1995, pp. 159-164
PATTERNS OF DRUG-TREATMENT OF SCHIZOPHRENIC-PATIENTS IN ESTONIA, SPAIN AND SWEDEN
Authors: KIIVET RA LLERENA A DAHL ML ROOTSLANE L VEGA JS EKLUNDH T SJOQVIST F
Citation: Ra. Kiivet et al., PATTERNS OF DRUG-TREATMENT OF SCHIZOPHRENIC-PATIENTS IN ESTONIA, SPAIN AND SWEDEN, British journal of clinical pharmacology, 40(5), 1995, pp. 467-476
POLYMORPHIC DRUG-METABOLISM IN SCHIZOPHRENIC-PATIENTS WITH TARDIVE-DYSKINESIA
Authors: ARTHUR H DAHL ML SIWERS B SJOQVIST F
Citation: H. Arthur et al., POLYMORPHIC DRUG-METABOLISM IN SCHIZOPHRENIC-PATIENTS WITH TARDIVE-DYSKINESIA, Journal of clinical psychopharmacology, 15(3), 1995, pp. 211-216
EUROPEAN JOURNAL OF CLINICAL-PHARMACOLOGY BECOMES THE OFFICIAL ORGAN OF CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS
Authors: CHEYMOL G ORNE M SJOQVIST F
Citation: G. Cheymol et al., EUROPEAN JOURNAL OF CLINICAL-PHARMACOLOGY BECOMES THE OFFICIAL ORGAN OF CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS, European Journal of Clinical Pharmacology, 48(5), 1995, pp. 317-318
ULTRARAPID HYDROXYLATION OF DEBRISOQUINE IN A SWEDISH POPULATION - ANALYSIS OF THE MOLECULAR-GENETIC BASIS
Authors: DAHL ML JOHANSSON I BERTILSSON L INGELMANSUNDBERG M SJOQVIST F
Citation: Ml. Dahl et al., ULTRARAPID HYDROXYLATION OF DEBRISOQUINE IN A SWEDISH POPULATION - ANALYSIS OF THE MOLECULAR-GENETIC BASIS, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 516-520
THE USE OF THERAPEUTIC DRUG-MONITORING DATA TO DOCUMENT KINETIC DRUG-INTERACTIONS - AN EXAMPLE WITH AMITRIPTYLINE AND NORTRIPTYLINE
Authors: JERLING M BERTILSSON L SJOQVIST F
Citation: M. Jerling et al., THE USE OF THERAPEUTIC DRUG-MONITORING DATA TO DOCUMENT KINETIC DRUG-INTERACTIONS - AN EXAMPLE WITH AMITRIPTYLINE AND NORTRIPTYLINE, Therapeutic drug monitoring, 16(1), 1994, pp. 1-12
GENETIC-ANALYSIS OF THE CHINESE CYTOCHROME P4502D LOCUS - CHARACTERIZATION OF VARIANT CYP2D6 GENES PRESENT IN SUBJECTS WITH DIMINISHED CAPACITY FOR DEBRISOQUINE HYDROXYLATION
Authors: JOHANSSON I OSCARSON M YUE QY BERTILSSON L SJOQVIST F INGELMANSUNDBERG M
Citation: I. Johansson et al., GENETIC-ANALYSIS OF THE CHINESE CYTOCHROME P4502D LOCUS - CHARACTERIZATION OF VARIANT CYP2D6 GENES PRESENT IN SUBJECTS WITH DIMINISHED CAPACITY FOR DEBRISOQUINE HYDROXYLATION, Molecular pharmacology, 46(3), 1994, pp. 452-459
POLYMORPHIC 2-HYDROXYLATION OF DESIPRAMINE - A POPULATION AND FAMILY STUDY
Authors: DAHL ML ISELIUS L ALM C SVENSSON JO LEE D JOHANSSON I INGELMANSUNDBERG M SJOQVIST F
Citation: Ml. Dahl et al., POLYMORPHIC 2-HYDROXYLATION OF DESIPRAMINE - A POPULATION AND FAMILY STUDY, European Journal of Clinical Pharmacology, 44(5), 1993, pp. 445-450
INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE
Authors: JOHANSSON I LUNDQVIST E BERTILSSON L DAHL ML SJOQVIST F INGELMANSUNDBERG M
Citation: I. Johansson et al., INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE, Proceedings of the National Academy of Sciences of the United Statesof America, 90(24), 1993, pp. 11825-11829
Risultati: 1-21 |